Shin, Hyunjae
Park, Youngsu
Song, Byeong Geun
Choi, Won-Mook
Han, Hyung Joon
Lee, Youngwoo
Song, Tae-Jin
Yeon, Jong-Eun
Lim, Young-Suk
Hur, Moon Haeng
Lee, Yun Bin
Cho, Eun Ju
Yu, Su Jong
Kim, Yoon Jun
Lee, Joon Hyeok
Yoon, Jung-Hwan
Lee, Jeong-Hoon
Article History
Received: 18 November 2025
Accepted: 5 January 2026
First Online: 27 January 2026
Declarations
:
: Yun Bin Lee: Receives research grants from Samjin Pharmaceuticals and Yuhan Pharmaceuticals; Su Jong Yu: Receives research grants from Yuhan Pharmaceuticals and Daewoong Pharmaceuticals; Yoon Jun Kim: Receives research grants from BTG, Boston Scientific, AstraZeneca, Gilead Sciences, Samjin, BL&H, and Bayer, and lecture fees from Roche, Abbvie, Eisai, Boston Scientific, BMS, BTG, Bayer, MSD, Novo Nordisk, GC Cell, Boehringer Ingelheim, and Gilead Sciences; Jung-Hwan Yoon: Receives research grants from Bayer, Daewoong Pharmaceuticals, and Bukwang Pharmaceutical; Jeong-Hoon Lee: Receives research grants from Yuhan Pharmaceuticals and GC Cell, and lecture fees from GC Cell, Daewoong Pharmaceuticals, and Gilead Korea; All other authors: Nothing to declare.